Our recent studies have provided evidence that in breast cancer up-regulation of DDX3 expression can be associated with an aggressive phenotype and down-regulation or targeted inhibition of DDX3 can mitigate its actions [19]. This evidence concerns the gene DDX3X and breast carcinoma.